Brainomix specializes in the creation of AI-powered software solutions to enable precision medicine for better treatment decisions in #stroke and #lung fibrosis
#ATS2026 is just over a week away, and we're excited to connect with everyone in sunny Orlando! ☀️ You won't want to miss these two exciting e-Lung sessions we have. Be sure to stop by the Brainomix booth (#2250) to meet our team and see e-Lung in action.🫁 @atscommunity
📣 Brainomix and @Boehringer Advance Strategic Partnership in Pulmonary Fibrosis 🚀We’re expanding our partnership after strong early results for e-Lung in earlier PPF diagnosis. Next: PROGRESS PPF, a multicenter US study evaluating impact at scale. prnewswire.com/news-releases/…
📣 Brainomix Extends Series C Financing to $25.4M (£18.8M) to Support U.S. Expansion
Additional funding will enhance Brainomix's industry-leading customer support and fast-track product advancements across its stroke and lung AI imaging platforms.